ABN AMRO Bank N.V. purchased a new stake in The Allstate Corporation (NYSE:ALL – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 17,510 shares of the insurance provider’s stock, valued at approximately $3,658,000.
A number of other large investors have also recently bought and sold shares of the company. MV Capital Management Inc. bought a new position in Allstate in the 4th quarter valued at about $25,000. Dorato Capital Management acquired a new stake in shares of Allstate during the 4th quarter worth approximately $27,000. Navalign LLC bought a new position in Allstate in the fourth quarter valued at approximately $27,000. Princeton Global Asset Management LLC increased its stake in Allstate by 101.3% in the fourth quarter. Princeton Global Asset Management LLC now owns 151 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 76 shares during the last quarter. Finally, Palisade Asset Management LLC acquired a new position in Allstate during the third quarter valued at approximately $31,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Andrea Redmond sold 2,225 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the transaction, the director owned 2,225 shares of the company’s stock, valued at $451,474.75. This represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Mario Rizzo sold 18,578 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $218.80, for a total transaction of $4,064,866.40. Following the completion of the transaction, the chief operating officer owned 82,227 shares of the company’s stock, valued at approximately $17,991,267.60. This trade represents a 18.43% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 22,353 shares of company stock valued at $4,851,560. 1.55% of the stock is currently owned by corporate insiders.
Allstate Stock Performance
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.65 EPS for the quarter, beating analysts’ consensus estimates of $7.31 by $3.34. Allstate had a return on equity of 42.66% and a net margin of 17.81%.The company had revenue of $16.94 billion during the quarter, compared to analysts’ expectations of $15.24 billion. During the same period in the prior year, the company earned $3.53 EPS. Allstate’s revenue was up 3.0% compared to the same quarter last year. On average, equities analysts expect that The Allstate Corporation will post 29.75 EPS for the current fiscal year.
Allstate Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be given a $1.08 dividend. The ex-dividend date is Monday, June 1st. This represents a $4.32 annualized dividend and a yield of 1.8%. Allstate’s dividend payout ratio (DPR) is currently 9.53%.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the company. Barclays upped their target price on Allstate from $207.00 to $208.00 and gave the stock an “underweight” rating in a research note on Wednesday, April 8th. Keefe, Bruyette & Woods lowered Allstate from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $266.00 to $242.00 in a research note on Monday, June 8th. Mizuho lowered their price target on Allstate from $281.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, March 20th. Weiss Ratings restated a “buy (a-)” rating on shares of Allstate in a research report on Thursday, June 18th. Finally, Citigroup raised their price objective on Allstate from $221.00 to $226.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Three investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and a consensus price target of $240.33.
Read Our Latest Research Report on ALL
Allstate Company Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Further Reading
- Five stocks we like better than Allstate
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
